MacLeod R M, Robyn C
J Endocrinol. 1977 Mar;72(3):273-7. doi: 10.1677/joe.0.0720273.
The effect of sulpiride, a neuroleptic agent, on the secretion of prolactin by the anterior pituitary gland of the rat was studied. A significant increase in serum prolactin was observed after subcutaneous administration of the drug. Although sulpiride (0-10 micronmol/1 or 0-14 mmol/1) had no effect on the secretion of newly synthesized or radioimmunoassayable prolactin in vitro, the drug significantly overcame the inhibitory action that dopamine (0-50 micronmol/1) exerted on prolactin secretion. Rats implanted with a prolactin-secreting pituitary tumour MtTW15 showed an inhibition of prolactin biosynthesis and release. Injection of these rats with sulpiride restored prolactin biosynthesis and release of the hormone toward normal levels. These results demonstrate that sulpiride has a direct effect on the pituitary antagonizing the inhibitory effects exerted by dopaminergic mechanisms, although the drug itself does not stimulate the secretion of prolactin in vitro. Sulpiride may have a direct action on the pituitary lactotrophs in vivo, but effects at higher centres have not been excluded.
研究了抗精神病药物舒必利对大鼠垂体前叶催乳素分泌的影响。皮下注射该药物后,观察到血清催乳素显著增加。尽管舒必利(0 - 10微摩尔/升或0 - 14毫摩尔/升)在体外对新合成的或可通过放射免疫测定的催乳素分泌没有影响,但该药物显著克服了多巴胺(0 - 50微摩尔/升)对催乳素分泌的抑制作用。植入分泌催乳素的垂体肿瘤MtTW15的大鼠表现出催乳素生物合成和释放受到抑制。给这些大鼠注射舒必利可使催乳素生物合成和激素释放恢复到正常水平。这些结果表明,舒必利对垂体有直接作用,拮抗多巴胺能机制所发挥的抑制作用,尽管该药物本身在体外不刺激催乳素分泌。舒必利在体内可能对垂体催乳细胞有直接作用,但尚未排除其在更高中枢的作用。